Weber, MM
-G. Stalla (Hrsg). Therapielexikon Endokrinologie und Stoffwechselkrankheiten. Springer-Verlag Berlin Heidelberg New York 2007
Gramont, A; Tournigand, C
Adjuvant therapy for stage II and III colorectal cancer.Semin Oncol. Bd. 34. H. Sup1. 2007 S. S37-40
Möhler, M; Galle, PR
Aktuelle Diagnostik und Therapie des MagenkarzinomsZ Gastroenterol. Bd. 2. H. 3. 2007 S. 17-32
Neufert, C; Becker, CH; Neurath, MF
An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression.Nat Protoc. Bd. 2. H. 8. 2007 S. 1998-2004
Hanefeld, M; Marx, N; Pfutzner, A et al.
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.J Am Coll Cardiol. Bd. 49. H. 3. 2007 S. 290-7
Grifoni, D; Garoia, F; Bellosta, P et al.
aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.Oncogene. Bd. 26. H. 40. 2007 S. 5960-5
Mudter, J; Neurath, MF
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.Gut. Bd. 56. H. 2. 2007 S. 293-303
Wilhelm, B; Klein, J; Friedrich, C et al.
Augmentation index as parameter for cardiovascular disease is increased in patients with diabetes mellitus. 51. Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 115. 2007 S. PO1-033
Wilhelm, B; Weber, MM; Ekberg, K et al.
C-Peptid führt zu einer Steigerung des Glukosemetabolismus sowohl bei Patienten mit einem Typ 1 Diabetes als auch bei gesunden Kontrollen.Diabetes und Stoffwechsel. H. S1. 2007 S. P222
Wirtz, S; Neufert, C; Weigmann, B et al.
Chemically induced mouse models of intestinal inflammation.Nat Protoc. Bd. 2. H. 3. 2007 S. 541-6